Yin Z, Wang X, Li N, Ni X, Jiang F, Li Y, Li J
Department of Hepatobiliary Surgery, Xiamen University Zhongshan Hospital, Xiamen, Fujian Province, PR China.
Transplant Proc. 2006 Dec;38(10):3251-2. doi: 10.1016/j.transproceed.2006.10.100.
We developed a new porcine model for auxiliary liver/small bowel transplantation (LSBT). The possible immunological advantage on small bowel graft induced by simultaneously transplanted liver in the large animal was assessed.
Thirty outbreed long-white pigs were randomized into two groups. Group A animals received LSBT without immunosuppressive treatment (n = 10). Group B animals had segmental small bowel allotransplantation without immunosuppressive treatment (n = 10). The postoperative survival time, initial acute rejection time, and pathological rejection scores were analyzed.
There was no remarkable difference in survival time between groups A and B (10.33 days vs 12.89 days, P > .05), but the initial time of acute rejection in intestinal grafts in group A was obviously delayed when compared to group B (8.22 days vs 4.33 days, P < .05), and the rejection scores in group A were remarkably lower than those of group B (0 vs 0.44 on postoperative day (POD) 3, P < .05; 0.22 vs 1.78 on POD 5, P < .05; 1.11 vs 2.56 on POD 7, P < .05).
An immunological advantage on intestinal graft can be induced by simultaneously transplanted liver in auxiliary LSBT. Compared to isolated segmental small bowel allotransplantation, the intestinal graft in LSBT has a delayed initial time of acute rejection and lower acute rejection scores. The liver graft may reduce the risk of intestinal rejection and thus protect the bowel graft.
我们开发了一种用于辅助性肝/小肠移植(LSBT)的新型猪模型。评估了在大型动物中同时移植肝脏对小肠移植物可能产生的免疫优势。
30只远交系长白猪被随机分为两组。A组动物接受LSBT且未进行免疫抑制治疗(n = 10)。B组动物接受节段性小肠同种异体移植且未进行免疫抑制治疗(n = 10)。分析术后存活时间、初始急性排斥反应时间和病理排斥评分。
A组和B组的存活时间无显著差异(10.33天对12.89天,P >.05),但与B组相比,A组肠移植物的初始急性排斥反应时间明显延迟(8.22天对4.33天,P <.05),且A组的排斥评分显著低于B组(术后第3天为0对0.44,P <.05;术后第5天为0.22对1.78,P <.05;术后第7天为1.11对2.56,P <.05)。
在辅助性LSBT中,同时移植肝脏可诱导对肠移植物的免疫优势。与单纯节段性小肠同种异体移植相比,LSBT中的肠移植物初始急性排斥反应时间延迟且急性排斥评分较低。肝移植物可能降低肠排斥反应的风险,从而保护肠移植物。